Advanced Accelerator Applications
Advanced Accelerator Applications, a Novartis company, specializes in radioligand therapy (RLT) for the treatment of cancer. The company develops and manufactures targeted medicines that deliver radiation directly to cancer cells while limiting damage to surrounding healthy tissue. Their portfolio focuses on oncology, specifically addressing therapeutic areas where molecular nuclear medicine can improve patient outcomes.
Biotechnology
Oncology
Pharmaceuticals
Healthcare
Funding summary
- Total raised
- €23.0M
- Funding rounds
- 1
- Exit
- buyout
- Exit value
- €41.0M
Investors in Advanced Accelerator Applications
Investors on record for Advanced Accelerator Applications. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Advanced Accelerator Applications?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors